CAR-T costs

CAR-T Cell Therapy in China: Breaking Down the Costs and Outcomes

7 approved CAR-T products, $120,000–220,000 vs $400,000+ in the US, clinical trial access from $40,000. China leads the world in CAR-T trial enrollment and has reduced manufacturing costs by 70%. A complete guide for international patients.